Boothbay Fund Management LLC Lowers Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Boothbay Fund Management LLC decreased its position in KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 95.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,424 shares of the company's stock after selling 253,658 shares during the quarter. Boothbay Fund Management LLC's holdings in KORU Medical Systems were worth $48,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Geode Capital Management LLC grew its holdings in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after purchasing an additional 28,323 shares in the last quarter. Calamos Advisors LLC bought a new position in KORU Medical Systems in the fourth quarter valued at approximately $250,000. White Pine Capital LLC boosted its holdings in KORU Medical Systems by 25.6% during the fourth quarter. White Pine Capital LLC now owns 157,917 shares of the company's stock worth $608,000 after buying an additional 32,176 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in KORU Medical Systems in the fourth quarter valued at approximately $104,000. Finally, Raymond James Financial Inc. bought a new position in KORU Medical Systems during the fourth quarter worth about $118,000. Institutional investors and hedge funds own 58.60% of the company's stock.

KORU Medical Systems Stock Performance

KORU Medical Systems stock traded down $0.02 during midday trading on Wednesday, reaching $2.72. The stock had a trading volume of 104,780 shares, compared to its average volume of 140,804. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $125.50 million, a PE ratio of -10.88 and a beta of 0.39. KORU Medical Systems, Inc. has a 12 month low of $1.86 and a 12 month high of $5.05. The firm's 50-day moving average price is $2.64 and its 200 day moving average price is $3.37.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.01). KORU Medical Systems had a negative net margin of 37.42% and a negative return on equity of 24.60%. As a group, research analysts predict that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

KRMD has been the subject of several analyst reports. Lake Street Capital raised their price objective on KORU Medical Systems from $4.00 to $5.00 and gave the company a "buy" rating in a report on Tuesday, January 14th. Craig Hallum boosted their price target on KORU Medical Systems from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, January 17th. B. Riley raised KORU Medical Systems to a "strong-buy" rating in a research note on Thursday, March 13th. Finally, Piper Sandler reissued a "neutral" rating and set a $4.50 target price on shares of KORU Medical Systems in a research note on Friday, February 14th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $4.70.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.